The Patent Finder

Commave Therapeutics S.A.

Also on record
Records under this name other than the patents Commave Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 7 of 7 · Back to Commave Therapeutics S.A.

PatentTitleStatus Expires Confidence
16/244,460Methylphenidate-Prodrugs, Processes of Making and Using the Same
Abandoned
Abandoned May 13, 2020
AbandonedAbandoned May 13, 2020
16/433,525Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof
Abandoned
Abandoned Jan 14, 2021
AbandonedAbandoned Jan 14, 2021
16/433,538Serdexmethylphenidate Conjugates, Compositions And Methods Of Use Thereof
Abandoned
Abandoned Sep 29, 2020
AbandonedAbandoned Sep 29, 2020
16/803,714Serdexmethylphenidate Conjugates, Compositions And Methods Of Use Thereof
Abandoned
Abandoned Sep 28, 2021
AbandonedAbandoned Sep 28, 2021
17/240,181Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Abandoned
Abandoned Mar 28, 2023
AbandonedAbandoned Mar 28, 2023
17/798,491Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/088,541Serdexmethylphenidate for Treatment of Idiopathic Hypersomnia
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited